Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia

Expert Review of Cardiovascular Therapy

Volumn 11, Issue 8, 2013, Pages 1061-1066

  Langslet, Gisle ^a   Ose, Leiv ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

children; familial hypercholesterolemia; genetic testing; metabolic disease; screening

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CHILD CARE; CLINICAL ASSESSMENT; COST EFFECTIVENESS ANALYSIS; FAMILIAL HYPERCHOLESTEROLEMIA; GENETIC SCREENING; HUMAN; POPULATION RESEARCH; REVIEW; SCREENING;

ADOLESCENT; CHILD; COST-BENEFIT ANALYSIS; EARLY DIAGNOSIS; FAMILY HEALTH; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MASS SCREENING; NETHERLANDS;

EID: 84887903148     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2013.814851     Document Type: Review

References (35)

1. Hopkins PN, Toth PP, Ballantyne CM, Rader DJ; National Lipid Association Expert Panel on Familial Hypercholesterolemia. Familial hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J. Clin. Lipidol. 5(3 Suppl.), S9-S17 (2011
2. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: The Metabolic and Molecular Bases of Inherited Disease (8th Edition). Scriver CR, Beaudet AL, Sly WS, Valle D (Eds.). McGraw-Hill Information Services, NY, USA, 2863-2913 (2001
3. No author listed. Mortality in treated heterozygous familial hypercholesterolaemia : Implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. Atherosclerosis 142(1), 105-112 (1999
4. Macchiaiolo M, Gagliardi MG, Toscano A, Guccione P, Bartuli A. Homozygous familial hypercholesterolaemia. Lancet 379(9823), 1330 (2012
5. Gr'sdal A, Bogsrud MP, Holven KB et al. Apheresis in homozygous familial hypercholesterolemia: The results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia. J. Clin. Lipidol. 6(4), 331-339 (2012
6. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ 303(6807), 893-896 (1991
7. Civeira F; International Panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 173(1), 55-68 (2004
8. Williams RR, Hunt SC, Schumacher MC et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am. J. Cardiol. 72(2), 171-176 (1993
9. Wiegman A, de GE, Hutten BA et al. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet 363(9406), 369-370 (2004
10. Rodenburg J, Vissers MN, Wiegman A et al. Statin treatment in children with familial hypercholesterolemia: The younger, the better. Circulation 116(6), 664-668 (2007
11. Neil A, Cooper J, Betteridge J et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: A prospective registry study. Eur. Heart J. 29(21), 2625-2633 (2008
12. Versmissen J, Oosterveer DM, Yazdanpanah M et al. Efficacy of statins in familial hypercholesterolaemia: A long term cohort study. BMJ 337, a2423 (2008
13. Wilson JMG, Jungner G. Principles and practice of screening for disease. WHO Chronicle 22(11), 473 (1968
14. Screening for lipid disorders in children: US Preventive Services Task Force recommendation statement. Pediatrics 120(1), e215-e219 (2007
15. Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K; American Heart Association. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 107(11), 1562-1566 (2003
16. McCrindle BW, Urbina EM, Dennison BA et al.; American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee; American Heart Association Council of Cardiovascular Disease in the Young; American Heart Association Council on Cardiovascular Nursing. Drug therapy of high-risk lipid abnormalities in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 115(14), 1948-1967 (2007
17. Ritchie SK, Murphy EC, Ice C et al. Universal versus targeted blood cholesterol screening among youth: The CARDIAC project. Pediatrics 126(2), 260-265 (2010
18. Ned RM, Sijbrands EJ. Cascade Screening for Familial Hypercholesterolemia (FH). PLoS Curr. 3, RRN1238 (2011
19. Starr B, Hadfield SG, Hutten BA et al. Development of sensitive and specific age- And gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing. Clin. Chem. Lab. Med. 46(6), 791-803 (2008
20. Descamps OS, Tenoutasse S, Stephenne X et al. Management of familial hypercholesterolemia in children and young adults: Consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis 218(2), 272-280 (2011
21. Krawczak M, Cooper DN, Schmidtke J. Estimating the efficacy and efficiency of cascade genetic screening. Am. J. Hum. Genet. 69(2), 361-370 (2001
22. ten Asbroek AH, de Mheen PJ, Defesche JC, Kastelein JJ, Gunning-Schepers LJ. Results from a family and DNA based active identification programme for familial hypercholesterolaemia. J. Epidemiol. Community Health 55(7), 500-502 (2001
23. Umans-Eckenhausen MA, Defesche JC, Sijbrands EJ, Scheerder RL, Kastelein JJ. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet 357(9251), 165-168 (2001
24. Kusters DM, de BC, Widhalm K et al. Paediatric screening for hypercholesterolaemia in Europe. Arch. Dis. Child. 97(3), 272-276 (2012
25. Leren TP, Finborud TH, Manshaus TE, Ose L, Berge KE. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening. Community Genet. 11(1), 26-35 (2008
26. Huijgen R, Kindt I, Verhoeven SB et al. Two years after molecular diagnosis of familial hypercholesterolemia: Majority on cholesterol-lowering treatment but a minority reaches treatment goal. PLoS ONE 5(2), e9220 (2010
27. Wierzbicki AS, Humphries SE, Minhas R; Guideline Development Group. Familial hypercholesterolaemia: Summary of NICE guidance. BMJ 337, a1095 (2008
28. Wald DS, Bestwick JP, Wald NJ. Child-parent screening for familial hypercholesterolaemia: Screening needs a fresh approach. BMJ 335(7628), 599 (2007
29. Goldberg AC, Hopkins PN, Toth PP et al.; National Lipid Association Expert Panel on Familial Hypercholesterolemia. Familial hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J. Clin. Lipidol. 5(3 Suppl), S1-S8 (2011
30. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report. Pediatrics 128(Suppl. 5), S213-S256 (2011
31. Meulenkamp TM, Tibben A, Mollema ED et al. Predictive genetic testing for cardiovascular diseases: Impact on carrier children. Am. J. Med. Genet. A 146A(24), 3136-3146 (2008
32. de Jongh S, Kerckhoffs MC, Grootenhuis MA, Bakker HD, Heymans HS, Last BF. Quality of life, anxiety and concerns among statin-treated children with familial hypercholesterolaemia and their parents. Acta Paediatr. 92(9), 1096-1101 (2003
33. Wonderling D, Umans-Eckenhausen MA, Marks D, Defesche JC, Kastelein JJ, Thorogood M. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands. Semin. Vasc. Med. 4(1), 97-104 (2004
34. Ademi Z, Watts GF, Juniper A, Liew D. A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia. Int. J. Cardiol. (2013
35. Vuorio A, Docherty KF, Humphries SE, Kuoppala J, Kovanen PT Statin treatment of children with familial hypercholesterolemia - trying to balance incomplete evidence of long-term safety and clinical accountability: Are we approaching a consensus? Atherosclerosis 226(2), 315-320 (2013